If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPanthera Res. Regulatory News (PAT)

Share Price Information for Panthera Res. (PAT)

Share Price is delayed by 15 minutes
Get Live Data
20.95    -0.80 (-3.76%)
Bid:
20.40
Ask:
21.50
Spread: 1.10 (5.392%)
Market Cap: £53.16m
PAT Live PriceLast checked at - London Stock Exchange

Intraday Panthera Res. Share Chart

Republic Investment Financing Restructured

8 Aug 2019 07:00

RNS Number : 3195I
Panthera Resources PLC
08 August 2019
 

8 August 2019

Panthera Resources Plc

("Panthera" or "the Company")

Republic Investment Management (RIM) Financing Restructured

 

Panthera Resources plc (AIM: PAT), the gold exploration and development company with assets in India and West Africa, is pleased to announce it has negotiated a restructuring of the previous agreed financing package with RIM, which will result in an immediate capital injection of £500,000 at 10 pence per share. The Company has agreed to issue 5,000,000 New Ordinary Shares to RIM and its co-investors.

Highlights

·; The previously agreed RIM financing will be restructured to split the Tranche 3 capital injection into two separate investment tranches.

·; Tranche 3A will be invested immediately for gross proceeds of £500,000 at 10 pence per share. The payment timing for Tranche 3B will be made (as previously agreed) upon receipt of approvals to recommence exploration at the Bhukia JV project in India. Tranche 3B is now to be priced at a 15% discount to the 20 day VWAP at that time.

·; This financing is a prudent move to sure up the company's balance sheet in response to delays to the permitting of the Company's Bhukia JV in India. 

Geoff Stanley, Managing Director said "Panthera Resources has worked diligently to negotiate multiple financing options that are integrated with its project development requirements, particularly as they relate to India. This successful financing is an excellent example of the success that can be achieved with supportive shareholders who share the Company's vision for value creation."

Funding Context

The RIM Tranche 3 financing was originally intended to provide initial funding for the recommencement of exploration drilling at the Bhukia JV upon grant of the prospecting licence (PL) and necessary environmental and forestry permits. The original Tranche 3 size was A$2.7m (£1.5m). As the PL grant has been further delayed, but protected by a Court Order, Panthera's capital budgeting has been negatively affected, necessitating this capital raise.

Additionally, subsequent to the original RIM financing, Panthera finalised a transaction with Galactic Gold Mining Pvt Ltd (Galaxy) in December 2018, which is also designed to provide funding for the recommencement of exploration at Bhukia. Galaxy has currently invested US$500,000 and the agreement requires Galaxy to invest a further US$750,000 to purchase another 5% stake in Panthera's Indian operating company, Indo Gold Pty Ltd.

Accordingly, despite the acceleration of part of the RIM Tranche 3 financing, Panthera remains well situated with respect to future funding to rapidly recommence exploration at Bhukia upon grant of the required PL. The combination of the future Galaxy investment and the RIM Tranche 3B financing will provide approximately A$2.6m (US$1.8m, GBP £1.3m) at the appropriate time to begin drilling out Bhukia's 6.7Moz exploration target as defined by the Geological Survey of India.

The 5,000,000 New Ordinary Shares are expected to be admitted to trading on AIM on or around 21 August 2019. Following the issue of the New Ordinary Shares, the number of Ordinary Shares in issue in the Company will increase to 72,605,556.

For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued Ordinary Share capital of Panthera following this allotment consists of 72,605,556 Ordinary Shares with voting rights attached (one vote per share). There are no shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculation by which they will determine whether they are required to notify their interest in, or a change to their interest in, Panthera under the DTRs.

 

Enquiries

Panthera Resources PLC

Geoff Stanley (CEO) +1 (917) 941 7704

 

Nominated Advisor and Broker

RFC Ambrian +44 (0) 20 3440 6800

Rob Adamson

Bhavesh Patel

Charlie Cryer

 

Market Abuse Regulation (MAR) Disclosure

The information communicated in this announcement includes inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUBSBRKSAWRAR
Date   Source Headline
1st Jul 20267:00 amRNSConversion of Options
30th Jun 20265:15 pmRNSTotal Voting Rights
11th Jun 20267:08 amRNSConversion of Options
3rd Jun 20267:00 amRNS-ROnline Investor Webinar
29th May 20265:15 pmRNSTotal Voting Rights
21st May 20267:00 amRNSConversion of Options
6th May 20267:00 amRNSConversion of Options
30th Apr 20265:00 pmRNSTotal Voting Rights
14th Apr 20267:09 amRNSConversion of Options
9th Apr 20262:31 pmRNSIssue of Equity – In Lieu of Director Fees
2nd Mar 20267:00 amRNSArbitration Update
19th Jan 20267:00 amRNSBido Drilling Results
31st Dec 202512:45 pmRNSTotal Voting Rights
31st Dec 202512:45 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSHalf-year Financial Report
29th Dec 20257:00 amRNSHalf-year Financial Report
11th Dec 20257:00 amRNSWarrant Conversion
3rd Dec 20257:00 amRNSWarrant Conversion
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20258:59 amRNSWarrant Conversion
21st Nov 20257:00 amRNSKalaka Metallurgical Study Results
20th Nov 20252:00 pmRNSWarrant Conversion
17th Nov 20257:00 amRNSOTCQB Approval
12th Nov 20257:00 amRNSOTC Application
3rd Nov 202511:02 amRNSIssue of Equity - Warrant Conversion and Fees
31st Oct 20255:05 pmRNSTotal Voting Rights
29th Oct 20257:00 amRNSArbitration Update
16th Oct 20255:05 pmRNSWarrant Conversion
9th Oct 202510:31 amRNSWarrant Conversion
8th Oct 20257:00 amRNSArbitration Financing Facility Update
3rd Oct 202511:30 amRNSResult of AGM
29th Sep 20257:00 amRNSChange of Registered Office
18th Sep 20257:00 amRNSArbitration Update
29th Aug 20255:00 pmRNSTotal Voting Rights
27th Aug 20257:58 amRNS2025 Annual Financial Report
8th Aug 20257:00 amRNSOption Conversion
4th Aug 20257:00 amRNSCommencement of Cascades Feasibility Study
25th Jul 20257:32 amRNSWarrant Conversion
18th Jul 20257:00 amRNSBido Drilling
19th May 20257:00 amRNSUS$1.58 billion Claim for Damages
30th Apr 20255:00 pmRNSTotal Voting Rights
16th Apr 20253:54 pmRNSIssue of Equity - Warrant Conversion and Fees
31st Mar 20255:00 pmRNSTotal Voting Rights
27th Mar 20257:00 amRNSIssue of Equity - Conversion of Options
20th Mar 202510:37 amRNSWarrant Exercise
7th Mar 20255:35 pmRNSNotification of Major Holding
6th Mar 20254:45 pmRNSUpdate on Issue of Equity Fundraising
28th Feb 20255:32 pmRNSNotification of Major Holding
25th Feb 20257:47 amRNSResult of Placing and Subscription
24th Feb 20255:04 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.